GSK · GSK plc
$52.05
-1.17 (-2.20%)
At close · Jul 30
Market Cap
$106.59B
Shares
2.00B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-28 | — | |
| 6-K | 2026-07-24 | — | |
| 6-K | 2026-07-24 | — | |
| 6-K | 2026-07-22 | — | |
| 6-K | 2026-07-20 | — | |
| 6-K | 2026-07-17 | — | |
| 6-K | 2026-07-17 | — | |
| 6-K | 2026-07-16 | — | |
| 6-K | 2026-07-15 | — | |
| 6-K | 2026-07-14 | — | |
| 6-K | 2026-07-13 | — | |
| 6-K | 2026-07-13 | — | |
| 6-K | 2026-07-10 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-01 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-26 | — | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-23 | — | |
| 6-K | 2026-06-22 | — | |
| 6-K | 2026-06-17 | — | |
| 6-K | 2026-06-15 | — | |
| 6-K | 2026-06-12 | — | |
| 6-K | 2026-06-11 | — | |
| 6-K | 2026-06-10 | — | |
| 6-K | 2026-06-09 | — | |
| 6-K | 2026-06-09 | — | |
| 6-K | 2026-06-08 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-05-28 | — | |
| 6-K | 2026-05-27 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-20 | — | |
| 6-K | 2026-05-20 | — | |
| 6-K | 2026-05-19 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-05-11 | — | |
| 6-K | 2026-05-11 | — | |
| 6-K | 2026-05-11 | — | |
| 6-K | 2026-05-06 | — |
Showing 1–50 of 1,288 filings